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Abstract
Therapeutic resistance is a major barrier to improvement of outcomes for
patients with glioblastoma. The endoplasmic reticulum stress response (ERSR)
has been identified as a contributor to chemoresistance in glioblastoma; however
the contributions of the ERSR to radioresistance have not been characterized. In
this study we found that radiation can induce ER stress and downstream signaling
associated with the ERSR. Induction of ER stress appears to be linked to changes in
ROS balance secondary to irradiation. Furthermore, we observed global induction
of genes downstream of the ERSR in irradiated glioblastoma. Knockdown of ATF6, a
regulator of the ERSR, was sufficient to enhance radiation induced cell death. Also,
we found that activation of ATF6 contributes to the radiation-induced upregulation
of glucose regulated protein 78 (GRP78) and NOTCH1. Our results reveal ATF6 as a
potential therapeutic target to enhance the efficacy of radiation therapy.

Introduction

NF-κB, PI3K/Akt and cPLA2, have also been shown to be
induced by ionizing radiation (IR) in various cell models
[6-9]. In glioblastoma, induction of such pathways by IR
may contribute to adaptive mechanisms that allow cells
to survive radiation therapy, resulting in recurrent tumors.
A pathway of recent interest to many investigators,
due to its role in adaptive survival signaling in cancer, is
the endoplasmic reticulum stress response (ERSR) [10,
11]. The ERSR is a conserved cellular program that allows
cells to cope with unfolded-protein-stress resulting from
dysfunctions in cellular metabolism [12]. In normal cells,
the ERSR is regulated by activating transcription factor
6 (ATF6), inositol-requiring protein 1 (IRE1) and protein
kinase RNA-like ER kinase (PERK)[11]. These proteins
are localized in the ER membrane and relay signals from
the ER lumen to the cytosol and nucleus during ER stress
[11]. Survival signaling downstream of ATF6, IRE1 and

Glioblastoma, the most common primary malignant
brain tumor in adults, remains a diagnosis with dismal
prognosis. Even with the adoption of surgical resection
followed by concomitant chemo-radiation therapy and
adjuvant chemotherapy as the current standard of care,
the 5-year survival rate is 9.8% [1]. The poor outcome
of glioblastoma is attributed to the highly infiltrative,
proliferative and radioresistant nature of these tumors [2,
3]. The clinical relevance of radioresistance is evident
in the failed attempts to improve patient outcomes by
escalating radiation doses [4]. Radioresistance is thought
to result from the numerous molecular aberrations that
characterize glioblastoma, such as enhanced DNA damage
repair (DDR) and activation of pro-survival signaling
pathways [3, 5]. However some of these pathways, such as
www.impactjournals.com/oncotarget
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PERK converges on genes that promote ER-chaperone
synthesis, ER-associated degradation (ERAD) and ERmembrane biogenesis [12]. Since tumor cells grow and
spread rapidly, they often exhaust local blood supplies,
resulting in areas of nutrient deprivation and hypoxia [13].
These adverse conditions perturb the sensitive protein
folding environment in the ER, leading to ER stress [13].
Thus, in cancer cells, the ERSR is often deregulated
and promotes tumorigenicity, as the deletion of tumor
suppressors and/or activation of oncogenes favors cells
that survive during high protein synthesis and metabolic
stress [10, 13, 14]. Enhanced pro-survival signaling
resulting from ERSR has been found to promote resistance
to chemotherapy through upregulation of canonical targets
such as glucose regulatory protein 78 (GRP78)[15, 16],
and non-canonical targets such as Mcl-1 [17]. However
the impact of ERSR-associated survival signaling on
radioresistance in glioblastoma is unclear.
In previous work we identified GRP78 as a
radiation inducible protein in models of glioblastoma
and breast cancer [18]. Although GRP78 is a critical
pro-survival chaperone involved in ERSR [16],
upregulation of GRP78 by IR has not yet been shown
to be associated with activation of ERSR. In this report,
we show that IR can affect ER homeostasis and activate
the ERSR. We demonstrate that activation of the ATF6

pathway in irradiated glioblastoma cells accounts for
increased GRP78 levels, and that ATF6 contributes to
radioresistance in these cells. We also identified Notch1
as a novel transcriptional target of ATF6, with a potential
role in promoting an anti-apoptotic phenotype in irradiated
glioblastoma [19, 20]. Our findings support the notion
of targeting the ATF6 pathway as a potential strategy to
improve the efficacy of radiation therapy for glioblastoma.

Results
Ionizing radiation chronically alters cellular and
ER redox homeostasis and is associated with ER
membrane expansion
Previously we found that IR can enhance the
binding of peptides that target GRP78 in vivo [18].
GRP78 is a well-characterized marker and regulator of
ER stress. Since the biological effects of radiation are
primarily mediated by oxidative stress [21], radiationinduced ROS might be associated with changes in ER
homeostasis. We first examined the cellular ROS status
of D54 and LN827 human glioblastoma cells 48h post
irradiation (6 Gy) by using CellROX Deep Red Reagent

Figure 1: Ionizing radiation alters cellular redox and ER homeostasis in malignant gliomas. A. Measurement of total ROS
by flow cytometry of cells stained with CellRox Deep Red 48h after 6 Gy IR. B. The abundance of ER-tracker staining was assayed by flow
cytometry 48h after 6 Gy IR in cells pretreated with DMSO or 50uM trolox for 3h. C. The change in GFP excitation peak was measured
in cells transduced with MERO-GFP to determine ER-redox status 24, 48 and 72h after irradiation, shown is the ratio of fluorescence from
excitation at 473nm and 405nm. In all graphs, data shown are the Means ±SD (n = 3). *P < 0.05, ***P < 0.001, ****P < 0.0001.
www.impactjournals.com/oncotarget
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and flow cytometric analysis. We found that irradiated
D54 and LN827 had 45% [P < 0.001] and 78% [P < 0.05]
elevations in ROS respectively (Figure 1A). We then
evaluated the impact of IR on ER membrane expansion
by using the ER-membrane-specific probe ER-Tracker
Red. Flow cytometric analysis of D54 and LN827 cells
stained with ER-Tracker showed a 52% and 50% increase
in staining respectively 48h post IR [P < 0.0001], which
was attenuated when cells were pre-treated with 50 uM
Trolox for 2h prior to irradiation [P < 0.001](Figure 1B).
We measured the relative change in ER oxidative state by
using lentiviral transduction to express an ER localized
redox reporter, MERO-GFP, in D54 and LN827 cells.
The fluorescence emission at 510 nm was measured by
use of 473 nm and 405 nm excitation wavelengths, which
represent reduced and oxidized MERO-GFP populations
respectively [22]. In both cell lines, a progressive decrease
in the 473/405 ratio was observed 24-72h after 6 Gy IR
[D54: 0.07835 at 48h, P < 0.0001; LN827: 0.1032 at 48h,
P < 0.0001] (Figure 1C). As an assay control, we used
DTT to promote reduction of the ER lumen and found
that treatment with 5mM DTT for 30 min was sufficient
to increase the 473/405 ratio in both cell lines (Figure

S1A). We isolated total cellular membranes from D54 and
LN827 48h after irradiation and performed western blot
analysis to examine GRP94 and GRP78 expression. We
used VAPB as a loading control for the ER membrane,
and observed that both GRP94 and GRP78 levels were
increased in the membrane fraction 48h after irradiation
(Figure S1B). These data suggest that radiation-induced
oxidative stress triggers changes in ER homeostasis and
may promote ER stress.

Global induction of genes downstream of the ER
stress response in irradiated glioblastoma cells
The observation of increased ER-chaperone
expression, along with alterations in ER homeostasis,
prompted us to examine the possibility that IR might
be activating the ER stress response [23]. The ER stress
response is regulated by three transmembrane proteins
within the ER membrane: ATF6, IRE1 and PERK [11,
12]. To assay for activity of each pathway, we performed
quantitative RT PCR (qRT-PCR) using primers specific
for genes known to be downstream of each regulatory

Figure 2: Global induction of genes downstream of the ER stress response in irradiated glioblastoma cells. A. qRT-PCR

analysis of genes downstream of ATF6, IRE1 and PERK using total-RNA extracts from D54 and LN827 cells 48h after 6 Gy IR. B. Western
blot analysis of cleaved-ATF6, XBP1S and ATF4 in nuclear extracts from D54 cells harvested 48h after irradiation with 6 Gy. C. Western
blot analysis of phosphorylated eIF2α in whole-cell lysates from D54 cells harvested 48h after irradiation with 6 Gy. Shown beneath
the blots is the relative expression of the indicated proteins when compared to the respective untreated control. The values represent the
normalized densitometric output for each band divided by the corresponding loading control. In all graphs, data shown are the Means ±SD
(n = 3). *P < 0.05.
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Ionizing radiation activates the ATF6 pathway in
glioblastoma

arm of the ERSR [23, 24]. For the ATF6 pathway, we
assayed HERPUD1 and HYOU1 expression. For IRE1,
we assayed EDEM and XBP1-S, and for PERK, we
measured ATF4 and GADD34 levels. We found that IR (6
Gy) was associated with significant increases (P < 0.05) in
expression of each of these genes in D54 and LN827 cells
(Figure 2A). To validate our findings at the protein level,
we assayed the expression of ATF6, XBP1-S and ATF4 in
the nucleus of irradiated D54 cells. We found increased
abundance of ATF6, XBP1-S and ATF4 48h after
irradiation in nuclear fraction (Figure 2B). Furthermore,
we examined the phosphorylation status of eIF2α, a
proximal cytosolic target of activated PERK. We observed
increased phosphorylation eIF2α 48h after irradiation
(Figure 2C). Together, these findings support the notion
that IR can promote mRNA and protein expression, which
is consistent with activation of the ERSR in glioblastoma
cells.

ATF6 is known to be the primary transcriptional
regulator of several ER-chaperones, including GRP78
[25]. We determined if radiation can induce ATF6
transcriptional activity by co-transfecting D54 cells
with p5xATF6-GL3 [26] and siRNA targeting ATF6.
D54 cells were then treated with 6 Gy, and assayed for
luciferase activity 48h after irradiation. We observed a
2.7 fold increase in luminescence in the irradiated cells
[P < 0.0001] (Figure 3A). Irradiated cells that had been
transfected with ATF6 siRNA had a blunted response, with
a 1.4 fold increase in luminescence relative to the control
siRNA group. The difference in luminescence between
the irradiated control siRNA and ATF6 siRNA groups
was statistically significant [P = 0.0002]. We observed
elevations in GRP78 mRNA levels 48h after IR, where a
110% [P < 0.05] and 63% [P < 0.01] increase was found
in D54 and LN827 respectively (Figure S2B). To test the

Figure 3: Activation of the ATF6 pathway in glioblastoma by ionizing radiation. A. Luciferase assay for ATF6 transcriptional

activity. D54 cells were co-transfected with p5xATF6-GL3 and siRNA targeting ATF6. The cells were irradiated with 6 Gy and assayed
for luciferase activity 48h after IR. The relative activity normalized to control is shown. B. qRT-PCR analysis of HERPUD1 and GRP78
expression in D54 after knockdown of ATF6. Cells were treated with ATF6 siRNA for 48h prior to irradiation with 6 Gy, and harvested 48h
later. C. Western blot analysis of GRP78 in whole-cell lysates from D54 cells harvested at the indicated time-points after irradiation with 6
Gy. D. Western blot analysis of GRP78 in whole-cell lysates from D54 cells harvested 48h after irradiation with 3 and 6 Gy. E. Western blot
analysis of GRP78 in whole-cell lysates from D54 cells treated with ATF6 siRNA and 6 Gy IR. Cells were harvested 48h after irradiation.
Shown beneath the blots is the relative expression of the indicated proteins when compared to the respective untreated control. The values
represent the normalized densitometric output for each band divided by the corresponding loading control. In all graphs, data shown are the
Means ±SD (n = 3). *P < 0.05, ***P < 0.001, ****P < 0.0001.
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Targeting ATF6 attenuates proliferation and
clonogenic survival

requirement of ATF6 in mediating radiation induction
of its target genes, we silenced ATF6 and assayed for
HERPUD1 and GRP78 gene expression with qRT-PCR.
We found that knockdown of ATF6 resulted in attenuated
induction of ATF6 target genes, HERPUD1 and GRP78,
in both D54 [P < 0.05] (Figure 3B) and LN827 [P < 0.01]
(Figure S2C). We measured the abundance of GRP78
protein in the D54 glioblastoma cell line by western blot
analysis at 24, 48 and 72h after a 6 Gy dose of x-radiation.
We found that the levels of GRP78 protein were elevated
at the 48 and 72h time points (Figure 3C). Knockdown of
ATF6 was sufficient to abrogate GRP78 protein induction
(Figure 3E). In order to study the potential relationship
between radiation dose and induction of ATF6 activity, we
treated D54 cells with 3 Gy and 6 Gy and analyzed GRP78
protein expression 48h after irradiation. We observed dose
dependent increases in GRP78 levels (Figure 3D), which
were reproducible in LN827 cells (Figure S2A). These
results demonstrate that transcriptional activity of ATF6 is
enhanced by IR, and that ATF6 is required for upregulation
of GRP78 during the radiation response.

Through pro-survival signaling mediated by ATF6,
activation of the ER stress response has been shown
to contribute to enhanced viability in several cancers
[10, 27]. Thus, we hypothesized that the activation of
ATF6 by radiation-induced ER stress could play a role
in promoting the viability of irradiated glioblastoma.
To test this hypothesis, we silenced ATF6 and studied
proliferation and clonogenic survival. Proliferation assays
were performed after transiently transfecting D54, LN428
and LN827 with ATF6-specific siRNA prior to irradiation
(3 Gy), and allowed to proliferate for 96h. Persistent
knockdown of ATF6 after 96h was verified by western blot
analysis (Figure S2D). We found that in D54, LN428 and
LN827 cell lines, silencing ATF6 alone was sufficient to
attenuate cell proliferation (Figure 4A). Furthermore when
ATF6 knockdown was combined with 3 Gy irradiation,
we observed significantly reduced cell proliferation when

Figure 4: Knockdown of ATF6 attenuates cell proliferation and clonogenic survival in glioblastoma. A. Proliferation
assays of D54, LN428 and LN827. Cells were treated with siRNA targeting ATF6 for 48h prior to irradiation with 3 Gy, and proliferation
was determined using a colorimetric cell proliferation assay 96h after irradiation. B. Clonogenic assays for D54 and LN428. Cells were
treated with ATF6 siRNA for 48h and re-seeded at low density prior to irradiation with 3 Gy. After 7-10 days, colonies comprised of 50 or
more cells were scored. In all graphs, data shown are the Means ±SD (n = 5). **P < 0.01, ***P < 0.001, ****P < 0.0001.
www.impactjournals.com/oncotarget
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compared to the irradiated non-targeting siRNA (siCtrl)
group [Mean difference: 45% in D54, P < 0.0001; 23%
in LN428 P = 0.0015; 36% in LN827, P < 0.0001]
(Figure 4A). To rule out the potential off target effects
of this siRNA, we used an additional siRNA and shRNA
targeting ATF6. We found that the effect of these different
RNAi approaches was consistent with our primary results
(Figure S3B and S3D). Similarly, colony formation was
ascertained in D54 and LN428 cells following siRNA
treatment and 3 Gy. In D54, the combination of radiation
and ATF6-knockdown resulted in a 10 fold decrease in
mean surviving fraction when compared to the siCtrl
group [P < 0.001] (Figure 4B). Similar results were found
in LN428, where silencing ATF6 prior to radiation lead to
a 1.9 fold decrease in mean surviving fraction [P < 0.001]
(Figure 4B). In order to examine the impact of increasing
radiation dose on clonogenic survival in the context
of ATF6-knockdown, we studied clonogenic survival
using 0, 2, 4 and 6 Gy IR doses in D54 after treatment
with ATF6 siRNA. Significant reduction in clonogenic

survival was observed after targeting ATF6 in D54 cells
[Mean surviving fraction: 23%, 1.2% and 0.21% at 2, 4
and 6 Gy respectively; P < 0.05] (Figure S3A). Further
we investigated the effect of ATF6 knockdown on cellular
ROS levels. We found that knockdown of ATF6 alone
with two different siRNA constructs resulted in 1.2 and
1.3 fold increases in cellular ROS respectively (Figure
S4). When combined with irradiation, ATF6 knockdown
with two different siRNA constructs lead to a 1.5 and 1.7
fold increase in cellular ROS respectively (Figure S4).
These findings suggest that targeting ATF6 can enhance
the efficacy of IR, and that the effect of ATF6 knockdown
may involve altered regulation of cellular ROS.

Knockdown of ATF6 enhances radiation induced
cell death in glioblastoma
We began our characterization of the mode of
cell death induced by ATF6 knockdown by examining
apoptotic cell death with Annexin-V/PI assays. D54,

Figure 5: Knockdown of ATF6 enhances radiation-induced cell death in glioblastoma. A. Annexin V/PI assays of D54,

LN428 and LN827. Cells were treated with siRNA targeting ATF6 for 48h prior to irradiation with 3 Gy. Cells were stained with Annexin
V and PI 96h after irradiation, and analyzed by flow cytometry. B. Cleaved PARP assay in D54. Cells were treated with ATF6 siRNA for
48h prior to irradiation with 3 Gy, and analyzed 96h later by flow cytometry after staining with anti-cleaved PARP-PE antibody. C. Caspase
3/7 activity assay in D54. Cells were treated with ATF6 siRNA for 48h prior to irradiation with 3 Gy, and analyzed 48h later by micro-plate
reader D. qRT-PCR analysis of BCL2, BCL-XL, MCL1, and Survivin gene expression in D54 after knockdown of ATF6. In all graphs, data
shown are the Means ±SD (n = 3). **** P < 0.0001.
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ATF6 contributes to regulation of NOTCH1 gene
expression

LN428 and LN827 Cells were treated with ATF6 siRNA
and 3 Gy, and stained with Annexin-V and PI 96h later.
Flow cytometric analysis of the cells showed that ATF6
knockdown resulted in an increase in early apoptosis
(Annexin-V positive) and late apoptosis (Annexin-V +
PI positive). The mean percent of total population was
55.3% (P < 0.0001), 38.7% (P < 0.0001), and 33.1%
(P < 0.0001) in D54, LN428 and LN827 respectively
(Figure 5A). Similar results were observed when targeted
with another siRNA targeting ATF6 (Figure S5). ATF6
knockdown enhanced PARP cleavage by 3.2 fold in
D54, as detected by flow cytometry 96h after irradiation
with 3 Gy (P < 0.0001) (Figure 5B). We also examined
caspase 3/7 activity in D54 after ATF6 knockdown and
irradiation. Knockdown of ATF6 in D54, when combined
with irradiation, resulted in a 2.2 fold increase in caspase
3/7 activity (Figure 5C). Furthermore, qRT-PCR of D54
cells 48h after ATF6 siRNA treatment revealed a 67% and
44% downregulation of BCL2 and MCL1 gene expression
respectively (Figure 5D). These data indicate that ATF6
knockdown sensitizes glioblastoma cells to radiationinduced apoptosis.

The mechanisms by which ATF6 may be linked to
anti-apoptotic signaling are largely defined by its role in
regulation of the GRPs [10], of which GRP78 is known
to suppress caspase-7 activity [16, 28, 29] and potentiate
survival signaling through Akt [30, 31]. Recent studies
have demonstrated that the antiapoptotic transcriptome
in irradiated glioblastoma is widely altered, with several
genes having unknown upstream links to radiation
response [20]. Since our results support the notion that
ATF6 is a radiation-responsive transcription factor, we
hypothesized that ATF6 contributes to the regulation
of antiapoptotic genes after irradiation. We screened
radiation-responsive antiapoptotic genes [20] for putative
ATF6 binding sites [26] and identified BLC6, BTG2,
HMGB2 and NOTCH1 as potential targets of ATF6. We
used qRT-PCR to study gene expression of BLC6, BTG2,
HMGB2 and NOTCH1 in D54 cells treated with ATF6
siRNA. We found that NOTCH1 was induced by 51%

Figure 6: ATF6 contributes to regulation of NOTCH1 gene expression. A. qRT-PCR analysis of NOTCH1 expression in D54,
LN428 and LN827. Cells were treated with siRNA targeting ATF6 for 48h prior to irradiation with 6 Gy. All qRT-PCR analyses were
performed using cells harvested 48h after irradiation. B. Western blot analysis of cleaved-ATF6 and Notch-ICN1 in whole cell lysates of
D54 harvested 48h after treatment with ATF6 siRNA and irradiation with 6 Gy. Shown beneath the blots is the relative expression of the
indicated proteins when compared to the respective untreated control. The values represent the normalized densitometric output for each
band divided by the corresponding loading control. In all graphs, data shown are the Means ±SD (n = 4). **P < 0.01, ***P < 0.001, ****
P < 0.0001.
www.impactjournals.com/oncotarget
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is known to occur during ER stress, as the ERSR drives
synthesis of ER-membrane lipids and chaperones in order
to expand the protein folding capacity of the ER [12]. We
found expansion of the ER-membrane after irradiation,
and pre-treatment with a ROS scavenger was sufficient
to attenuate this expansion (Figure 1B). Similarly, we
observed increased abundance of both GRP78 and GRP94
(Figure S1B). Together, these results suggest that there is
a link between ROS generated by IR and changes in ERhomeostasis in glioblastoma. A mechanism by which IRinduced ROS can promote ER stress remains to be shown.
We postulate that lipid peroxidation secondary to IR could
affect the integrity of the ER membrane, thereby affecting
transport processes associated with ER homeostasis.
Alternatively, IR could be activating a secondary process
that may lead to gradual accumulation of ROS in the ER.
This is supported by our observation that ER-oxidation
increases gradually over several days (Figure 1C).
The hypothesis that IR can induce the ERSR in
glioblastoma was further supported by the observation of
global activation of gene targets downstream of each arm
of the ERSR: ATF6, IRE1 and PERK (Figure 2). Induction
of ERSR signaling by IR occurs in endothelial cells [35,
36] and IEC-6 intestinal epithelial cells [37]; however
these studies used doses of radiation upwards of 15 Gy.
IR induced ERSR signaling in cancer is supported by
IR induction of the PERK/eIF2a pathway [38, 39]. The
PERK pathway is often considered to be the switch in the
ERSR that regulates ER stress-induced cell death [40],
and is known to transiently promote survival during ER
stress [12]. Our findings suggest that the ATF6 and IRE1
pathways are also activated in irradiated glioblastoma cell
lines. These pathways are primarily associated with the
pro-survival aspects of the ERSR and may represent a
cellular mechanism by which glioblastoma could adapt to
therapeutic stress.
We further studied the ATF6 arm of the ERSR
because of its well established role as the primary regulator
of pro-survival chaperone synthesis, and also because of its
potential role as a radiation-responsive transcription factor.
Not only did we find that ATF6 transcriptional activity
was enhanced in irradiated glioblastoma (Figure 3A), but
we also found accumulation of GRP78, a major target of
ATF6, in a time and dose-dependent manner (Figure 3C
and 3D). Additionally, ATF6 was required for radiation
induction of GRP78 (Figure 3B and 3E). Enhanced
expression of GRP78 in glioblastoma has been associated
with increased resistance to temozolomide, cisplatin and
etoposide [28, 29], with proposed mechanisms involving
suppression of caspase-7 activation [41]. Silencing GRP78
in glioblastoma has been shown to increase sensitivity to
gamma-irradiation [28]. Furthermore, overexpression of
GRP78 has been observed in patient-derived recurrentglioblastoma specimens, and has been shown to inversely
correlate with progression-free survival [42]. In the
context of these studies, our findings suggest that radiation

(P < 0.01) at 48h after irradiation, and that this induction
was abrogated by ATF6 knockdown (Figure 6A). The
contribution of ATF6 to radiation-induction of NOTCH1
was also evident in LN428 and LN827 cell lines, where
knockdown of ATF6 attenuated radiation induction of
NOTCH1 gene expression from 35% to 4% in LN428, and
164% to 56% in LN827 (Figure 6A).
To validate these findings at the protein level, we
performed western blot analysis of cleaved-ATF6 and
Notch-ICN1 in D54 cells treated with siRNAs targeting
ATF6. We found that while irradiation was associated
with increased abundance of cleaved-ATF6 and NotchICN1, knockdown of ATF6 with two different siRNAs
was sufficient to abrogate induction of both cleavedATF6 and Notch-ICN1 (Figure 6B). To determine the
effect of Notch1 knockdown on radiation resistance, we
evaluated cell proliferation after knockdown of Notch1.
We found that knockdown of Notch1 alone reduced
cell proliferation by 18% (Figure S3B). When Notch1
knockdown was combined with irradiation, we observed
that cell proliferation was attenuated by 59% (Figure
S3B). In summary, these results demonstrate that ATF6
may be involved in regulating NOTCH1 mRNA and
protein expression, and that Notch1 may play a role in
promoting proliferation of irradiated glioblastoma cells.

Discussion
This study investigated mechanisms by which
IR could trigger stress responses in glioblastoma, and
determined if such stress responses could impact cell
survival. In this study, we found that by activating the
ERSR, IR can contribute to adaptive survival signaling
in glioblastoma through a mechanism that involves
regulation of ATF6.
In our first set of experiments, we studied a
potential link between irradiation and ER homeostasis in
glioblastoma cell lines. The ER is known to be responsive
to numerous forms of biochemical perturbation, including
calcium balance, metabolism and reduction/oxidation
[11]. IR has been shown to primarily alter ROS balance
in cells by triggering hydrolysis of water molecules,
thereby generating hydroxyl radicals [32]. Furthermore,
there have been reports that ROS can activate ER stress
signaling in gastric and colorectal cancer cell lines
[33, 34]. Thus, we hypothesized that IR could alter ER
redox balance in a manner that could promote ER stress.
This hypothesis was supported by our observation that
persistent elevations in cellular ROS occurred in our cell
lines after irradiation (Figure 1A), and our measurement
of an increased oxidative state specifically within the ER
lumen (Figure 1C). In order to examine whether these
changes in cellular and ER ROS coincided with gross
alteration in ER homeostasis, we investigated changes
in ER-membrane abundance and levels of GRP78 and
GRP94 ER chaperones. Expansion of the ER membrane
www.impactjournals.com/oncotarget
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of glioblastoma cells. Specifically, we identified the
ATF6 pathway of the ER stress response as a radiation
responsive signaling pathway, and NOTCH1 as a
previously unidentified target of ATF6 with a potential
role in mediating survival of glioblastoma cells during
the radiation response. While additional work is needed
to validate the mechanisms by which Notch1 may be
involved in promoting cell survival downstream of ATF6,
this investigation supports other studies identifying
Notch1 as a key component in therapeutic resistance
in glioblastoma. Furthermore, this work highlights the
potential for a new therapeutic strategy wherein targeting
of the ERSR through inhibition of ATF6 may serve to
enhance the efficacy of radiation therapy for glioblastoma.

induced ERSR signaling contributes to an adaptive prosurvival phenotype in glioblastoma that could result in
therapeutic resistance and tumor recurrence.
Given the potential for ATF6 activation to mediate
pro-survival signaling within glioblastoma, we silenced
ATF6 and measured cell sensitivity to IR. We found that
silencing ATF6 was sufficient to enhance the cytotoxic
effects of radiation in glioblastoma (Figure 4). The
enhanced cell death represented in the clonogenic survival
assays is likely due to potentiation of apoptotic signaling
during ATF6 knockdown (Figure 5). However, it is
possible that the mechanism of cell death may be more
complex, as recent literature suggests that necroptosis
is also activated by ER stress [43, 44]. Additional
investigations are needed to fully characterize the cell
death mechanisms that may be downstream of ER stress
and ATF6 knockdown in GBM. We have also found
that ATF6 knockdown results in altered cellular ROS
regulation and enhances the induction of ROS in irradiated
cells (Figure S4). However it remains to be shown how
ATF6 is involved in cellular ROS balance, and whether
deregulation of this process may contribute to increased
radiosensitivity. We hypothesize that the connection
between loss of ATF6 and reduced survival might be
explained by the downstream reduction of pro-survival
GRPs secondary to ATF6 knockdown.
While ATF6 has a well characterized role in
regulation of ER-stress chaperone synthesis, a search for
putative ATF6 binding sites (unfolded protein response
elements - UPRE) in the eukaryotic promoter database
reveals many genes thought to be unrelated to ER stress
[26, 45, 46]. This prompted us to examine the possibility
that ATF6 could be regulating other anti-apoptotic gene
targets. Transcriptomic analysis of irradiated glioblastoma
identified a number of anti-apoptotic genes with
consistently altered gene expression [20]. By screening this
list of genes for putative UPRE sequences, we identified
BCL6, NOTCH1, HMGB2 and BTG2 as potential targets
of ATF6. In our qRT-PCR analyses, we found that ATF6
contributed to NOTCH1 upregulation after irradiation
(Figure 6), but was dispensable for BCL6, HMGB2 and
BTG2 expression (Figure S6). The notch pathway is
critical to the differentiation of neural progenitor cells
during normal brain development, and has also been
linked to cellular responses to hypoxia and angiogenesis
[47]. Notch1, through regulation of PI3K/Akt activity
and Mcl-1, has been implicated in the radioresistance of
glioma initiating cells [19, 48]. Additionally, increased
Notch1 expression has been demonstrated in recurrent
glioblastomas after chemo-radiation therapy and was
identified as a prognostic marker for anti-angiogenic
therapy [49]. NOTCH1 expression could be, in part, a
product of ERSR signaling downstream of ATF6 in the
context of radiation response.
In summary, we found that radiation can induce ER
stress signaling in a manner that contributes to viability
www.impactjournals.com/oncotarget

Materials and Methods
Cell cultures and chemicals
The D54 cell line [50] was a generous gift from Dr.
Yancey Gellipsie. LN428 and LN827 [51]cell lines were
gifts from Dr. Joshua Rubin. 293T cells were obtained
from ATCC. D54 was maintained in DMEM with F-12
Nutrient Mixture in a 1:1 ratio, 10% fetal bovine serum
(FBS) and 1% penicillin-streptomycin (P/S). LN428 and
LN827 were maintained in DMEM with 10% FBS and 1%
P/S. 293T cells were maintained in DMEM low-glucose
with 10% FBS and 1% P/S. All cultures were grown at
37 °C in a humidified atmosphere with 5% CO2. Trolox,
2-deoxy-glucose, and thapsigargin were purchased from
Sigma (St. Louis, MO, USA). Radiation was administered
to cells at a dose rate of 2.5Gy/min by means of a RS2000
160kV X-ray Irradiator with a 0.3 mm copper filter (Rad
Source Technologies, Suwanee, GA, USA).

Lentiviral transduction
pLenti-MERO-GFP plasmid was a kind gift from
Dr. Fumihiko Urano. Lentiviruses were constructed
by co-transfecting pLenti-MERO-GFP, the packaging
plasmid (pCMV-dR8.2), and the envelope plasmid
(pCMV-VSV-G) into 293T cells using Fugene 6 (Roche,
Mannheim Germany). Transfections were carried out for
18h, after which the culture medium was changed. Viral
supernatants were harvested 48h after transfection, and
used to infect 100,000 target cells in the presence of 10 ug/
ml polybrene. Cells were incubated with virus supernatant
for 18h, after which they were allowed to recover for
24h before selection with 2 ug/ml puromycin for 72h.
Puromycin-resistant cells were then used in downstream
assays.
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Quantitative real-time PCR analysis

were collected and stained with Annexin V-FITC and PI
(BD Biosciences, San Jose, CA, USA) according to the
manufacturer’s protocol. Stained cells were analyzed by
flow cytometry.

RNA was extracted with TRIZOL reagent (Life
Technologies, Foster City, CA, USA) and isolated with
RNeasy Mini Kit (Qiagen, Germantown, MD, USA). 1 µg
of RNA was used to produce cDNA with High Capacity
cDNA Reverse Transcrptase Kit (Applied Biosystems,
Foster City, CA, USA). Primer sequences were obtained
from the Primer Bank [52-54] (Supplementary Table
1.) and were used in quantitative real-time PCR (qRTPCR) with a 7900HT Real-Time PCR System (Applied
Biosystems). The delta-delta Ct method for quantitation of
relative gene expression was used to determine the mean
expression of each target gene normalized to the geometric
mean of actin and GAPDH.

Luciferase assays
Plasmids encoding p5xATF6-GL3 was a gift
from Dr. Ron Prywes (Addgene plasmid #11976). D54
cells grown in 60 mm plates were transfected with 2
ug of p5xATF6-GL3 using Fugene 6 according to the
manufacturer’s protocol. After transfecting for 18h, cells
were re-plated and allowed to adhere prior to irradiation
with 6 Gy IR. 48h after IR, the cells were lysed and
assayed for luciferase activity using Luciferase Assay
System (Promega, Madison, WI, USA) and a microplate
reader.

Measurement of ER oxidation status

Capsase activity assay

ROS levels in the ER were measured in D54 and
LN827 cells transduced with MERO-GFP. Cells were
irradiated with 6 Gy, and trypsinized at the expirmental
end-point. 15,000 viable cells were added to each well of
a 96-well plate, after which the fluorescence at 510 nm
was measured from the 405 nm and 473 nm excitation
wavelengths with a SpectraMax i3 microplate reader
(Molecular Devices, Sunnyvale, CA, USA). The 473/405
nm fluorescence ratio was then calculated for each
treatment group.

Cells were seeded in 96-well plates after transfection
with siRNA. Cells were irradiated with 3 Gy and Caspase
3/7 activity was measured using Caspase-Glo assay kit
(Promega, Madison USA) according to the manufacturer’s
protocol.

Western immunoblot analysis
M-PER mammalian protein extraction reagent
(Thermo-Pierce, Rockford, IL, USA) was used to extract
total soluble protein from cells. For extraction of cellular
membrane proteins, the Proteo Extract Subcellular
Proteome Extraction Kit (Millipore, Lake Placid, NY,
USA) was used according to the manufacturer’s protocol.
For extraction of nuclear proteins, NE-PER Nuclear and
Cytoplasmic Extraction Reagents were used (Thermo).
Concentrations of cell lysates were determined by BCA
assays, and equal amounts of protein were resolved by
SDS-PAGE and transferred to PVDF membranes for
immunoblotting. GRP78 and VAPB antibodies were from
ProteinTech (Chicago, IL, USA). Notch1 and GAPDH
antibodies were from Cell Signaling Technology (Danvers,
MA, USA). Tubulin antibody was from Sigma. Blots were
imaged with a ChemiDoc-MP Imaging System (Bio-Rad
Laboratories, Hercules, CA, USA), and analyzed with
Image Lab Software (Bio-Rad).

Flow cytometry
i) Cellular ROS studies
D54 and LN827 cells were treated with or without
radiation. At the experimental endpoint, 5 uM CellROX
Deep Red Reagent (Life Technologies) was added to cell
culture media and incubated for 30 min at 37 °C. Cells
were washed with PBS, collected, and analyzed by flowcytometry with a MACSQuant Analyzer (Miltenyi Biotec,
San Diego, CA, USA).
ii) ER tracker studies
100,000 D54 and LN827 cells were seeded in
6-well plates and treated with 50 uM trolox for 3h prior to
irradiation with 6 Gy. Cells were washed twice with PBS,
and complete medium was added to the wells. 48h after
treatment, media was changed to 1 uM ER-Tracker Red
(Life Technologies) in HBSS and left to incubate for 30
min at 37 °C. The cells were then washed twice with fresh
HBSS, collected, and analyzed by flow cytometry.

Transfection of siRNA
Silencer-select pre-designed siRNAs against
ATF6 (s223544 and s22688), NOTCH1 (s9634) and
non-targeting control siRNA were purchased from
Life Technologies/Ambion. Lipofectamine RNAiMax
transfection reagent (Life Technologies/Ambion) was used

iii) Annexin V/PI studies
D54, LN827 and LN428 cells were transfected
with siRNA and re-seeded in 6-well plates for radiation
treatments. 96h after irradiation with 3 Gy, the cells
www.impactjournals.com/oncotarget
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Clonogenic survival assays
Cells were seeded at defined cell densities according
to radiation dose and allowed to attach overnight. Cells
were then irradiated with 0, 2, 3, 4, or 6 Gy. After
incubating for 7-10 days, plates were stained with 0.5%
crystal violet. Colonies comprised of 50 cells or more
were counted and the counts were normalized to plating
efficiency and represented as surviving fraction relative to
control (sham/non-targetting siRNA).
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